Lymphomas and leukemias due to infectious organisms

References

• Poiesz BJ, Ruscetti FW, Reitz MS, Kalyanaraman VS, Gallo RC. Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sezary T-cell leukaemia. Nature. 1981;294:268–71.
   PubMed Web of Science ®Google Scholar
• Hinuma Y, Komoda H, Chosa T, Kondo T, Kohakura M, Takenaka T, et al.. Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study. Int J Cancer. 1982;29:631–5.
   PubMed Web of Science ®Google Scholar
• Sawada Y, Hino R, Hama K, Ohmori S, Fueki H, Yamada S, et al.. Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia/lymphoma. Blood. 2011;117:3961–7.
   PubMed Web of Science ®Google Scholar
• Tannir N, Riggs S, Velasquez W, Samaan N, Manning J. Hypercalcemia, unusual bone lesions, and human T-cell leukemia-lymphoma virus in adult T-cell lymphoma. Cancer. 1985;55:615–9.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Yamaguchi K, Takatsuki K, Osame M, Yoshida M. Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene. J Exp Med. 1990;172:759–65.
   PubMed Web of Science ®Google Scholar
• Ejima E, Rosenblatt JD, Massari M, Quan E, Stephens D, Rosen CA, et al.. Cell-type-specific transactivation of the parathyroid hormone-related protein gene promoter by the human T-cell leukemia virus type I (HTLV-I) tax and HTLV-II tax proteins. Blood. 1993;81:1017–24.
   PubMed Web of Science ®Google Scholar
• Ishitsuka K, Tamura K. Treatment of adult T-cell leukemia/lymphoma: past, present, and future. Eur J Haematol. 2008;80:185–96.
   PubMed Web of Science ®Google Scholar
• Gill PS, Harrington W Jr, Kaplan MH, Ribeiro RC, Bennett JM, Liebman HA, et al.. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med. 1995;332:1744–8.
   PubMed Web of Science ®Google Scholar
• Bazarbachi A, Plumelle Y, Carlos Ramos J, Tortevoye P, Otrock Z, Taylor G, et al.. Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes. J Clin Oncol. 2010;28:4177–83.
   PubMed Web of Science ®Google Scholar
• Phillips AA, Willim RD, Savage DG, Horwitz SM, Isola L, Zain JM, et al.. A multi-institutional experience of autologous stem cell transplantation in North American patients with human T-cell lymphotropic virus type-1 adult T-cell leukemia/lymphoma suggests ineffective salvage of relapsed patients. Leuk Lymphoma. 2009;50:1039–42.
   PubMed Web of Science ®Google Scholar
• Kato K, Kanda Y, Eto T, Muta T, Gondo H, Taniguchi S, et al.. Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program. Biol Blood Marrow Transplant. 2007;13:90–9.
   PubMed Web of Science ®Google Scholar
• Matsuoka M, Jeang KT. Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy. Oncogene. 2011;30:1379–89.
   PubMed Web of Science ®Google Scholar
• Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L, et al.. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood. 1996;87:4296–301.
   PubMed Web of Science ®Google Scholar
• Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Mizokami M, et al.. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med. 1997;127:423–8.
   PubMed Web of Science ®Google Scholar
• Levine AM, Shimodaira S, Lai MM. Treatment of HCV-related mantle-cell lymphoma with ribavirin and pegylated interferon Alfa. N Engl J Med. 2003;349:2078–9.
   PubMed Web of Science ®Google Scholar
• Hermine O, Lefrere F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Saudreau V, et al.. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med. 2002;347:89–94.
   PubMed Web of Science ®Google Scholar
• Vallisa D, Bernuzzi P, Arcaini L, Sacchi S, Callea V, Marasca R, et al.. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin’s lymphoma: a multicenter Italian experience. J Clin Oncol. 2005;23:468–73.
   PubMed Web of Science ®Google Scholar
• Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, et al.. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994;330:1267–71.
   PubMed Web of Science ®Google Scholar
• Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Gastric lymphoma and Helicobacter pylori. N Engl J Med. 1994;330:1310–1.
   PubMed Web of Science ®Google Scholar
• Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, et al.. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993;342:575–7.
   PubMed Web of Science ®Google Scholar
• Stathis A, Chini C, Bertoni F, Proserpio I, Capella C, Mazzucchelli L, et al.. Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type. Ann Oncol. 2009;20:1086–93.
   PubMed Web of Science ®Google Scholar
• Fischbach W, Goebeler ME, Ruskone-Fourmestraux A, Wundisch T, Neubauer A, Raderer M, et al.. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series. Gut. 2007;56:1685–7.
   PubMed Web of Science ®Google Scholar
• Zullo A, Hassan C, Andriani A, Cristofari F, Bassanelli C, Spinelli GP, et al.. Treatment of low-grade gastric MALT-lymphoma unresponsive to Helicobacter pylori therapy: a pooled-data analysis. Med Oncol. 2010;27:291–5.
   PubMed Web of Science ®Google Scholar
• Gobbi PG, Corbella F, Valentino F, Bergonzi M, Sangalli C, Perfetti V, et al.. Complete long-term response to radiotherapy of gastric early-stage marginal zone lymphoma resistant to both anti-Helicobacter pylori antibiotics and chemotherapy. Ann Oncol. 2009;20:465–8.
   PubMed Web of Science ®Google Scholar
• Martinelli G, Laszlo D, Ferreri AJ, Pruneri G, Ponzoni M, Conconi A, et al.. Clinical activity of rituximab in gastric marginal zone non-Hodgkin’s lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. J Clin Oncol. 2005;23:1979–83.
   PubMed Web of Science ®Google Scholar
• Cuoco L, Cammarota G, Tursi A, Papa A, Certo M, Cianci R, et al.. Disappearance of gastric mucosa-associated lymphoid tissue in coeliac patients after gluten withdrawal. Scand J Gastroenterol. 1998;33:401–5.
   PubMed Web of Science ®Google Scholar